THE ORDINARY GLYCOLIC ACID 7% EXFOLIATING TONER
- Contains 7% Glycolic Acid for effective exfoliation.
- Targets dullness and uneven texture.
- Improves skin radiance and clarity.
- Includes Tasmanian Pepperberry, ginseng root, and aloe vera for soothing effects.
- Suitable for all skin types, but caution advised for sensitive skin.
Description:
The Ordinary Glycolic Acid 7% Exfoliating Toner is a powerful exfoliating solution that helps to improve skin texture and radiance. Formulated with 7% Glycolic Acid, this toner gently exfoliates the skin, removing dead skin cells and promoting a brighter, more even complexion. The formula is enhanced with Tasmanian Pepperberry to reduce irritation, ginseng root for its skin-soothing properties, and aloe vera to provide hydration. Ideal for use in the evening, this toner is suitable for most skin types, although those with sensitive skin should use it with caution. Regular use can lead to visibly smoother and clearer skin.
Related products
-
CERAVE DRY ROUGH BUMPY SKIN SA SOOTHING CLEANSER 236ML
Original price was: ₨7,100.00.₨6,390.00Current price is: ₨6,390.00.
Brand :CeraVe
Item Weight:0.28 Kilograms -
ESTEE LAUDER ADVANCED NIGHT REPAIR SYNCHRONIZED MULTI-RECOVERY COMPLEX UNISEX 1.7 OZ
Original price was: ₨23,630.00.₨21,270.00Current price is: ₨21,270.00.
Skin Type: Normal
Product Benefits :Our 1 serum to powerfully fight the look of multiple signs of aging.
Use for: Face
Scent :Advanced Night Repair Synchronized Multi-Recovery
Special Ingredients :Jojoba Seed Oil -
THE ORDINARY SALICYLIC ACID 2% MASK 30 ML
Original price was: ₨3,840.00.₨3,450.00Current price is: ₨3,450.00.
Treat
A clarifying face masque that targets dull, blemish-prone skin.
Targets
Signs of Congestion, Dullness, Textural Irregularities
Suited to
Oily Skin
Format
Masque
Key ingredients
Salicylic Acid, Kaolin, Charcoal Powder, 4-t-Butylcyclohexanol
-
CERAVE PM FACIAL MOISTURISING LOTION ULTRA LIGHTWEIGHT 89ML
Original price was: ₨5,000.00.₨4,500.00Current price is: ₨4,500.00.
Reviews
There are no reviews yet.